Delivery Order SPE2DB22D2007-SPE2DB25FJ4BU
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Afinitor Disperz 3 mg tablets in quantities of 28 units. This competitively awarded, non-set-aside contract carries a ceiling value of $47,663.84 under firm fixed pricing terms, with an ultimate completion date of September 8, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Afinitor 10 mg tablets. The contract has a ceiling value of $20,805.32 and a period of performance ending on September 20, 2024. The contract is a firm-fixed-price type, with no set-aside designation. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,600.94, is a Firm Fixed Price Delivery Order for the supply of the drug Afinitor 2.5 mg tablet, with a completion date of May 2, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of Afinitor Disperz 3 mg tablets. The contract has a ceiling value of $20,344.14 and an ultimate completion date of October 11, 2024. It is a firm-fixed-price contract type. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of prescription medications, medical supplies, and equipment to various...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,891.25 Firm Fixed Price Delivery Order contract is for the supply of AFINITOR 2.5 MG TABLET UD 28S, a pharmaceutical product. The contract has an ultimate completion date of November 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $24,721.64 firm fixed-price delivery order is for the supply of AFINITOR 10 MG TABLET UD 28S, a pharmaceutical product, with a completion date of March 5, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $10,447.08, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as a firm fixed price delivery order. The contract is for the supply of Afinitor 7.5 mg tablets, a specialty pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor and has been awarded an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 by DLA to...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,831.92, is for the supply of AFINITOR DISPERZ 3 MG TABLET 28S, a medical product. The contract has an ultimate completion date of February 14, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Afinitor 10 mg tablets, a specialty pharmaceutical product. The contract has a ceiling value of $41,610.64 and an ultimate completion date of October 21, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to various government agencies,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Everolimus 1 mg tablets in unit dose packaging (60 count) under a firm fixed-price contract valued at $10,949.64. This delivery order, which is a child award under AmerisourceBergen's broader contract vehicle, represents a competitive award with no set-aside designation and is scheduled for completion by August 20, 2025. The product will be delivered to AmerisourceBergen's...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4BUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Afinitor 10 mg tablets in unit dose packaging (28 count) with a ceiling value of $12,360.81. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, maintains a substantial federal contracting portfolio predominantly with the Defense Logistics Agency and its Medical Supply Chain. The company regularly supplies an extensive range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems. No set-aside designation was applied to this award, indicating it was competitively procured on an open basis, consistent with AmerisourceBergen's demonstrated capability to fulfill federal medical procurement requirements across diverse therapeutic domains and order values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.4k | 8/19/25 |